Obermatt
See Similar Stocks →

Ceribell

NSQ:CBLL · US15678C1027
Health Care Equipment & SuppliesSmall

360

37
Profit price68
Owner Earnings Yield1
Dividend Yield1
Price/Sales22
EV / Gross Profit28
Price/Book18
Return on Capital17
Cash Return on Capital22
Return on Equity33
EBIT Margin10
Gross Profitability68
Accruals7
Owner Earnings Margin18
Sales growth89
Profit Growth6
Long-Term EPS Growth94
Reinvestment86
Price momentum52
Debt load73
Refinancing29
Debt Payback1
Liquidity7
Analyst ratings76
Opinion Changes50
Price Target Upside58
Market mood7
Value Creation4/20not creating value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Ceribell doesn't consistently earn more than its cost of capital, so it isn't yet creating shareholder value.

Profile

CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
TypePublic Company
ExchangeNASDAQGS
Founded2014
Employees344
Websiteceribell.com
ISINUS15678C1027
Last UpdateApr 2, 2026
Indices
NASDAQ (USA)
Themes
Assistive TechnologyArtificial IntelligenceHealth DiagnosticsBiomedical EngineeringNeurologyNeuroscienceDetectors, Sensors and MemsWearablesSensorsBiotechnologyHealth CareMedical Device

Description

CeriBell, Inc. operates as a medical technology company that focuses on transforming the diagnosis and management of patients with serious neurological conditions. The company has developed the Ceribell System, a novel, point-of-care EEG platform sp…

Analysis

Weak and unloved

CeriBell, Inc. is weak and unloved: below-average business metrics and a price that reflects that disappointment.

Valuation data is not available for this company.

The trajectory is moderate and the balance sheet is adequate. The company scores 4/20 on our value-creation score: not creating value.

Nothing is flagged here: no red or amber gates, no divergence between profits and cash. That is itself information: the numbers are straightforward. As always: this describes the company's numbers; it is not a recommendation.

360° rank · history

1007550250
22
2026

All-time high

28

Mar 2026

All-time low

22

Jun 2026

Average rank

25

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
22
—
—
—
Price/Earnings
92
—
—
—
Price/Book
18
—
—
—
Dividend Yield
1
—
—
—
Value (overall)
30
—
—
—

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Ceribell with its peers
GE Healthcare
NSQ:GEHC
32
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeX-Large
Full Stock Analysis →
Heartbeam
NAQ:BEAT
10
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeX-Small
Full Stock Analysis →
Integra LifeSciences
NSQ:IART
21
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeLarge
Full Stock Analysis →
Hyperfine
NMQ:HYPR
30
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →
NeuroPace
NMQ:NPCE
30
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →
Inogen
NSQ:INGN
39
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →